SHANGHAI and GEMBLOUX, Belgium and HEIDELBERG, Germany, Jan. 3, 2024 /PRNewswire/ — Full-Life Technologies (“Full-Life”), a fully integrated global radiotherapeutics company, today announced the completion of $63.3 million financing, comprised of $47.3 million in Series B equity financing and $16 million in loan facilities. The financing will advance development of the Company’s radiopharmaceutical pipeline and manufacturing… Continue reading Global radiotherapeutics company Full-Life Technologies announces USD $47.3 million Series B financing, Prosperity7 Ventures jointly leads the round
Category: Newswire
Full-Life Technologies, das globale Radiotherapeutik-Unternehmen, schließt Serie-B-Finanzierungsrunde in Höhe von 47,3 Mio. US-Dollar ab – Prosperity7 Ventures führt die Runde an
SHANGHAI, GEMBLOUX, Belgien, und HEIDELBERG, Deutschland, 4. Januar 2024 /PRNewswire/ — Full-Life Technologies („Full-Life”), ein vollständig integriertes, globales Radiotherapeutik-Unternehmen, hat heute den Abschluss einer Finanzierungsrunde im Umfang von 63,3 Mio. US-Dollar abgeschlossen, die sich aus einer Serie-B-Eigenkapitalfinanzierung in Höhe von 47,3 Mio. US-Dollar und 16 Mio. US-Dollar Kreditfazilitäten zusammensetzt. Die Finanzierung wird die Entwicklung der Radiopharmazeutika-Pipeline und der… Continue reading Full-Life Technologies, das globale Radiotherapeutik-Unternehmen, schließt Serie-B-Finanzierungsrunde in Höhe von 47,3 Mio. US-Dollar ab – Prosperity7 Ventures führt die Runde an
Condor Software Achieves SOC 1 Type 2 Certification
SAN DIEGO, Jan. 3, 2024 /PRNewswire/ — Condor Software, a leading provider of clinical trial financial management nationwide, today announced that it has successfully completed a Service Organization Control (SOC) 1 Type 2 audit. The audit, conducted by Baker Tilly, an independent auditing firm, provides assurance that Condor Software’s controls related to financial reporting are… Continue reading Condor Software Achieves SOC 1 Type 2 Certification
Anonymous Health Launches Innovative Addiction Care Services in Alaska
ANCHORAGE, Alaska, Jan. 3, 2024 /PRNewswire/ — Anonymous Health, a pioneer in outpatient teletherapy services, is proud to announce its launch in Alaska. This marks a significant step in addressing the complex challenges of addiction care across the state. “We are excited to help address long-standing capacity and access challenges of addiction care in Alaska,” said… Continue reading Anonymous Health Launches Innovative Addiction Care Services in Alaska
Global Workspace Delivery Network Markets Report 2023: Digital Transformation Spurs Demand, Scalability and Flexibility Key to Growth – Forecasts to 2028
DUBLIN , Jan. 3, 2024 /PRNewswire/ — The “Workspace Delivery Network Market by Type (Traditional WAN, SD-WAN), Application (IT and Telecommunication, Government Institutions, Research and Consulting Services, and Others), and Region 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global workspace delivery network market size reached US$ 2 Billion in 2022. Looking forward, the publisher expects the market… Continue reading Global Workspace Delivery Network Markets Report 2023: Digital Transformation Spurs Demand, Scalability and Flexibility Key to Growth – Forecasts to 2028
FCA Reports Fourth-quarter and Full-year 2023 Sales Results
AUBURN HILLS, Mich., Jan. 3, 2024 /PRNewswire/ — FCA 2023 U.S. sales decreased 1% year over year; Q4 2023 sales decreased 1% over same quarter last year Total PHEV U.S. sales increased 124% year over year and 118% versus same quarter last year Chrysler brand 2023 U.S. sales increased 19% year over year Dodge brand 2023… Continue reading FCA Reports Fourth-quarter and Full-year 2023 Sales Results
Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
EMERYVILLE, Calif., Jan. 3, 2024 /PRNewswire/ — Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11 at 11:15 a.m. PT. The presentation will be webcast and may be accessed through the “Events… Continue reading Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CMI INVESTOR NEWS: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cummins Inc. Investors to Inquire About Securities Class Action Investigation – CMI
NEW YORK , Jan. 3, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cummins Inc. (NYSE: CMI) resulting from allegations that Cummins may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cummins securities… Continue reading CMI INVESTOR NEWS: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cummins Inc. Investors to Inquire About Securities Class Action Investigation – CMI
Global Rare Earth Magnet Market Report 2023: A $17.5 Billion Industry in 2022 – Trends, Share, Size, Growth, Opportunity and Forecasts to 2028
DUBLIN, Jan. 3, 2024 /PRNewswire/ — The “Rare Earth Magnet Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The global rare earth magnet market size reached US$ 17.5 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 24.8 Billion by 2028,… Continue reading Global Rare Earth Magnet Market Report 2023: A $17.5 Billion Industry in 2022 – Trends, Share, Size, Growth, Opportunity and Forecasts to 2028
AusperBio Welcomes Dr. Will Wei as Head of CMC
SAN FRANCISCO, Jan. 3, 2024 /PRNewswire/ — AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (Together AusperBio), a clinical-stage biotechnology company committed to advancing oligonucleotide therapies, with a primary focus on achieving a functional cure for chronic hepatitis B (CHB) infection, today announced that Dr. Will Wei has joined the company as Head of CMC,… Continue reading AusperBio Welcomes Dr. Will Wei as Head of CMC